Galena Biopharma Inc (NASDAQ:GALE) entered the oncology marketplace with its March 2013 acquisition of fentanyl (Abstral), a sublingual treatment for breakthrough cancer pain. Now the company is looking to expand its presence in the oncology field by developing and acquiring targeted cancer agents. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $3.67 in last session, and closed at $3.91, while the day range of stock is $3.66 – $4.12. The stock showed a negative weekly performance of -9.91%.
Raptor Pharmaceutical Corp (NASDAQ:RPTP) has announced top line result on its planned 18 month analysis of an ongoing 3 year phase trial for potential treatment of Huntington disease in collaboration with Centre Hospitalier Universitaire d’Angers. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) stock opened at $17.05, in last session and closed at $17.14, by gaining 14.88%. The 52 week range of the stock is $4.87 – $17.72. Company’s market capitalization is $1.05 billion.
Shares of Infoblox (NASDAQ:BLOX) were upgraded from Neutral to Buy by Goldman Sachs Thursday morning. The firm maintains a $27 price target on the stock. Infoblox Inc (NYSE:BLOX) stock advanced 11.05% and finished the last session at $21.31. The EPS of the stock remained -0.09. Company’s market capitalization is $1.13 billion.
Penn Virginia Corporation (NYSE:PVA) soars to a new 52-week high despite missing Q4 earnings forecasts as some Eagle Ford wells were brought online later than expected and anticipated 2014 capex is increasing due to increased leaseholds. Penn Virginia Corporation (NYSE:PVA) stock opened the session at $12.48, and closed the session at $14.03. The 52 week range of the stock remained $3.56 – $14.22 and the day range was $12.25 – $14.22.